PMID: 29438Oct 1, 1978

Glaucoma treatment with timolol

Acta Ophthalmologica
E Kerty, I Hørven

Abstract

Thirty-two eyes from 19 patients with either capsular glaucoma, pigmentary glaucoma or primary open angle glaucoma were given topical timolol and followed through a 3--6 months period. Twelve eyes were previously out of control on full medication including pilocarpine, epinephrine and acetazolamide. Eight of these eyes could be adequately controlled throughout the follow-up period on topical timolol or a combination of timolol and pilocarpine, but without resorting to acetazolamide. One eye needed acetazolamide in combination with timolol, and three eyes had to be referred to surgery. Twelve eyes were adequately controlled either on pilocarpine or full medication, but could be equally well controlled on timolol alone, or timolol and pilocarpine in combination. Acetazolamide could be withheld from all of the six patients who used this drug. Eight eyes were previously untreated. They could all be adequately controlled either on timolol (5 eyes) or timolol and pilocarpine (3 eyes). The study indicates that the effect of timolol 0.5% X 2 may be stronger than the combined effect of epinephrine 1% X 2 and acetazolamide 500 mg a day. Topical timolol was well tolerated. No side reactions occurred and the pupillary size and reactions we...Continue Reading

References

Jun 1, 1975·The British Journal of Ophthalmology·M J ElliotC I Phillips
Apr 1, 1977·Archives of Ophthalmology·T J Zimmerman, H E Kaufman
Apr 1, 1977·Archives of Ophthalmology·T J Zimmerman, H E Kaufman
Feb 1, 1978·Acta Ophthalmologica·R RitchS M Podos
Jan 1, 1974·Acta Ophthalmologica·M Pandolfi, A Ohrström
Jan 1, 1973·Acta Ophthalmologica·A Ohrström
Jul 24, 1970·Documenta Ophthalmologica. Advances in Ophthalmology·J François, A Neetens
Apr 1, 1967·The British Journal of Ophthalmology·C I PhillipsD J Rowlands

Citations

Jul 2, 1979·Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie. Albrecht Von Graefe's Archive for Clinical and Experimental Ophthalmology·M Ober, A Scharrer
Dec 1, 1980·Acta Ophthalmologica·B M Calissendorff, N Marén
Oct 2, 2019·Expert Opinion on Therapeutic Patents·Emanuela Berrino, Claudiu T Supuran
Jan 1, 1979·Acta Ophthalmologica·N V Nielsen, J S Eriksen
Jan 1, 1979·Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie. Albrecht Von Graefe's Archive for Clinical and Experimental Ophthalmology·A Scharrer, M Ober
Sep 1, 1981·The British Journal of Ophthalmology·J V Thomas, D L Epstein
Aug 1, 1994·Acta Ophthalmologica·R J Uusitalo, A Palkama
Jun 1, 1979·Acta Ophthalmologica·N V Nielsen, J S Eriksen
Dec 1, 1979·The British Journal of Ophthalmology·P J AiraksinenE A Jaanio
Aug 1, 1979·Acta Ophthalmologica·H AasvedJ E Slagsvold
Jan 1, 1982·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·K K TakkiO Valle

Related Concepts

Administration, Topical
Adrenergic beta-Antagonists
Drug Evaluation
Polychemotherapy
Glaucoma
Physiologic Intraocular Pressure
Salagen
Propanolamines
Timoptol

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Synthetic Genetic Array Analysis

Synthetic genetic arrays allow the systematic examination of genetic interactions. Here is the latest research focusing on synthetic genetic arrays and their analyses.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Computational Methods for Protein Structures

Computational methods employing machine learning algorithms are powerful tools that can be used to predict the effect of mutations on protein structure. This is important in neurodegenerative disorders, where some mutations can cause the formation of toxic protein aggregations. This feed follows the latests insights into the relationships between mutation and protein structure leading to better understanding of disease.

Congenital Hyperinsulinism

Congenital hyperinsulinism is caused by genetic mutations resulting in excess insulin secretion from beta cells of the pancreas. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Epigenetic Memory

Epigenetic memory refers to the heritable genetic changes that are not explained by the DNA sequence. Find the latest research on epigenetic memory here.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Femoral Neoplasms

Femoral Neoplasms are bone tumors that arise in the femur. Discover the latest research on femoral neoplasms here.